I agree that this site is using cookies. You can find further informations here.
X
Slama, Borhane
96  results:
Search for persons X
?
1

Isatuximab, lenalidomide, dexamethasone and bortezomib in t..:

Leleu, Xavier ; Hulin, Cyrille ; Lambert, Jerome...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
2

Final results on effectiveness and safety of Ibrutinib in p..:

Dartigeas, Caroline ; Quinquenel, Anne ; Ysebaert, Loïc...
Annals of Hematology.  , 2024
Link: https://doi.org/10.1007/..
 
?
3

Clinical characteristics and outcome of 318 families with f..:

Dumontet, Charles ; Demangel, Delphine ; Galia, Perrine...
American Journal of Hematology.  98 (2023)  2 - p. 264-271 , 2023
Link: https://doi.org/10.1002/..
 
?
4

A phase II study of lenalidomide and rituximab (R2) combina..:

Noel, Robin ; Zemmour, Christophe ; Montes de Oca, Catalina...
Hematology.  28 (2023)  1 - p. , 2023
Link: https://doi.org/10.1080/..
 
?
5

PB1755: CLINICAL FEATURES AND BIOLOGICAL CHARACTERIZATION O..:

Dutari, Pilar ; Adjoumani, Tantrantan Leonce ; Chebrek, Safia...
HemaSphere.  7 (2023)  S3 - p. e4666516 , 2023
Link: https://doi.org/10.1097/..
 
?
6

FIRE Study: Real-World Effectiveness and Safety of Ibrutini..:

Dartigeas, Caroline ; Slama, Borhane ; Doyle, Margaret...
Clinical Hematology International.  4 (2022)  3 - p. 65-74 , 2022
Link: https://doi.org/10.1007/..
 
?
7

Prospective validation of a biomarker-driven response predi..:

Kubasch, Anne Sophie ; Giagounidis, Aristoteles ; Metzgeroth, Georgia...
Leukemia.  , 2022
Link: https://doi.org/10.1038/..
 
?
8

Real‐world clinical effectiveness and safety of CT‐P10 in p..:

Bishton, Mark J. ; Salles, Gilles ; Golfier, Camille...
eJHaem.  4 (2022)  1 - p. 45-54 , 2022
Link: https://doi.org/10.1002/..
 
?
9

Exome sequencing identifies germline variants in DIS3 in fa..:

Pertesi, Maroulio ; Vallée, Maxime ; Wei, Xiaomu...
Leukemia.  33 (2019)  9 - p. 2324-2330 , 2019
Link: https://doi.org/10.1038/..
 
?
10

Long‐term safety and efficacy of rituximab in 248 adults wi..:

Deshayes, Samuel ; Khellaf, Mehdi ; Zarour, Anissa...
American Journal of Hematology.  94 (2019)  12 - p. 1314-1324 , 2019
Link: https://doi.org/10.1002/..
 
?
11

A Prospective Phase II Trial of Lenalidomide and Dexamethas..:

Jaccard, Arnaud ; Karlin, Lionel ; Hebraud, Benjamin...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e41 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Validation of the revised international prognostic scoring ..:

de Swart, Louise ; Smith, Alex ; Johnston, Thomas W....
British Journal of Haematology.  170 (2015)  3 - p. 372-383 , 2015
Link: https://doi.org/10.1111/..
 
?
13

Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, ..:

Brecqueville, Mandy ; Rey, Jérôme ; Bertucci, François...
Genes, Chromosomes and Cancer.  51 (2012)  8 - p. 743-755 , 2012
Link: https://doi.org/10.1002/..
 
?
14

Low‐dose vs. high‐dose thalidomide for advanced multiple my..:

Yakoub‐Agha, Ibrahim ; Mary, Jean‐Yves ; Hulin, Cyrille...
European Journal of Haematology.  88 (2012)  3 - p. 249-259 , 2012
Link: https://doi.org/10.1111/..
 
?
15

Poly-exposition aux cancérogènes et reconnaissance en malad..:

Hunsmann, Moritz ; Amiet, Etienne ; Larrere, Solenne...
hal-04225523.  , 2023
Link: https://hal.science/hal-..
 
1-15